hotspot -WSS

hotspot

author：hotspot 2025-09-27 21:27:48 - browse：86

SAN DIEGO — After starting off the year with lower revenue projections than market analysts had hoped for, San Diego-based genomics giant Illumina lowered expectations again on Wednesday, forecasting annual growth of 1% compared to the previous year.

The market’s response was swift. Minutes after the company issued its press release, shares in Illumina dipped from $184.49 to below $172 during after-hours trading.

In its release, Illumina noted that it expects revenue from the company’s core business to be essentially the same this year compared to last, and that it expects revenue from Grail, the cancer diagnostics company that Illumina acquired for $8 billion in the fall of 2021, to remain in the range of $90 and $100 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

WSS

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Roche's accidental data boosts hopes for anti

Trump Jan. 6 attorney John Lauro is ex

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Moderna hits safety problems in bold bid to reinvent medicine

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Wikipedia

hotspot

focus

Medicare proposal to cover medical devices draws a mixed reaction

Vivek Ramaswamy made waves in the debate, much as in biotech

In Memoriam: Notable people who died in 2023

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

What does generative AI mean for health care? We asked experts

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

Peter Hotez and the public health issue of online harassment

Health officials lay out plans to cope with respiratory virus season

Supreme Court strikes down use of affirmative action

Meadows told special counsel he could not recall Trump ever declassifying Mar

hotspot

Abortion policy in the spotlight at Republican debate

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Roche's accidental data boosts hopes for anti

Listen: Vivek Ramaswamy's star turn & leaky drug data

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

hotspot

knowledge

hotspot

focus